KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Cme (CME) over the last 17 years, with Q3 2025 value amounting to -$1.4 billion.

  • Cme's Non Operating Income fell 5180.43% to -$1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.4 billion, marking a year-over-year decrease of 1654.82%. This contributed to the annual value of -$3.7 billion for FY2024, which is 2206.01% up from last year.
  • Per Cme's latest filing, its Non Operating Income stood at -$1.4 billion for Q3 2025, which was down 5180.43% from -$1.4 billion recorded in Q2 2025.
  • Cme's Non Operating Income's 5-year high stood at $482.2 million during Q3 2021, with a 5-year trough of -$1.4 billion in Q2 2023.
  • Moreover, its 5-year median value for Non Operating Income was -$920.0 million (2024), whereas its average is -$681.9 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 344861.11% in 2021, then crashed by 211538.46% in 2023.
  • Cme's Non Operating Income (Quarter) stood at $167.6 million in 2021, then plummeted by 706.98% to -$1.0 billion in 2022, then increased by 5.51% to -$961.2 million in 2023, then increased by 12.87% to -$837.5 million in 2024, then plummeted by 66.76% to -$1.4 billion in 2025.
  • Its Non Operating Income was -$1.4 billion in Q3 2025, compared to -$1.4 billion in Q2 2025 and -$802.4 million in Q1 2025.